Belite Bio (BLTE) Treasury Shares (2020 - 2025)

Belite Bio (BLTE) posted quarterly Treasury Shares of $155751.0 for Q4 2025, down 98.01% quarter-over-quarter from $7.8 million in Q4 2021.

Belite Bio (BLTE) Treasury Shares (2020 - 2025) Analysis & Trends

Belite Bio's Treasury Shares history runs 3 years deep, the most recent figure standing at $155751.0 for Q4 2025.

In Q4 2025, Treasury Shares changed N/A year-over-year to $155751.0; the TTM figure through Dec 2025 stood at $155751.0 (changed N/A YoY), while the FY2025 annual figure was $155751.0, changed N/A from the prior year.
Treasury Shares for Q4 2025 stood at $155751.0, down from $7.8 million in the prior quarter.
The five-year high for Treasury Shares was $7.8 million in Q4 2021, with the low at $155751.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	5.08 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	2.72 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	92,219.00
10	Belite Bio	6.40 Bn	6.40 Bn	-	-

Download Data